Search results

Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) caused by neurological conditions in adults.

Result type

Technology appraisal guidance

Published

9 October 2019

This guideline covers the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and management of headaches, with more targeted treatment to improve the quality of life for people with headaches, and to reduce unnecessary investigations.

Result type

Clinical guideline

Last updated

3 June 2025

Question Method of botulinum toxin type A injection in treating focal spasticity:- Is guided botulinum...

Result type

Research recommendation

Published

8 March 2019

Topic prioritisation

Result type

Interventional procedures guidance

Status

Topic prioritisation

What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women?...

Result type

Research recommendation

Published

21 June 2019

Summary of the evidence on 2% topical diltiazem hydrochloride for chronic anal fissure to inform local NHS planning and decision-making

Result type

Evidence summary

Published

22 January 2013

CG148/5 Question What is the safety and efficacy of botulinum toxin compared with (a) usual care, (b) antimuscarinics and...

Result type

Research recommendation

Published

9 June 2015

Topic prioritisation

Result type

Interventional procedures guidance

Status

Topic prioritisation

This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible.

Result type

NICE guideline

Published

25 January 2017

NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

Result type

Medtech innovation briefing

Published

28 March 2017

Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.

Result type

Technology appraisal guidance

Published

26 June 2013

Evidence-based recommendations on electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adults. This involves putting medicine into the bladder, then sending a small electrical current to the bladder to increase the medicine's absorption.

Result type

Interventional procedures guidance

Published

9 January 2025

This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

Result type

NICE guideline

Last updated

23 July 2019

Evidence-based recommendations on transcutaneous stimulation of the cervical branch of the vagus nerve to treat cluster headache and migraine in adults. This involves using a small handheld device to stimulate a nerve in the neck.

Result type

Interventional procedures guidance

Published

23 March 2016

Evidence-based recommendations on occipital nerve stimulation for intractable chronic migraine. This involves using implanted electrodes to deliver electrical impulses to the occipital nerve to mask migraine pain.

Result type

Interventional procedures guidance

Published

26 April 2013